These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3922388)

  • 1. Catecholamine-blocking drugs injected at sites of amine accumulation reverse catecholamine degeneration associated deficits.
    Willis GL; Smith GC
    Behav Brain Res; 1985 Apr; 15(2):101-6. PubMed ID: 3922388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for amine accumulation in the syndrome of ingestive deficits following lateral hypothalamic lesions.
    Willis GL; Smith GC
    Appetite; 1984 Sep; 5(3):239-67, 277-9. PubMed ID: 6441517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of dopamine receptors in the lateral hypothalamus is altered in 6-hydroxydopamine treated rats.
    Willis GL; Sandyk R
    Int J Neurosci; 1992; 65(1-4):199-207. PubMed ID: 1341683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amine accumulation in behavioural pathology.
    Willis GL; Smith GC
    Brain Res; 1985 Jun; 356(2):109-32. PubMed ID: 3924349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of experimental parkinsonism by intrahypothalamic administration of haloperidol.
    Willis GL; Smith GC; Pavey GM; Sandyk R
    Int J Neurosci; 1992; 65(1-4):187-97. PubMed ID: 1341681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feeding behavior after hypothalamic 6-hydroxydopamine injections.
    Leibowitz SF
    Appetite; 1984 Sep; 5(3):268-71. PubMed ID: 6441518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficits in locomotor behaviour and thermoregulation produced by intrahypothalamic dopamine injections.
    Willis GL; Smith GC
    Behav Brain Res; 1984 May; 12(2):137-43. PubMed ID: 6466433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral DA receptor blockade facilitates behavioural recovery from nigrostriatal damage.
    Willis GL; Smith GC; Kinchington PC
    Brain Res Bull; 1983 Jul; 11(1):15-9. PubMed ID: 6627037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioural effects of intrahypothalamic multistage versus single injections of 6-hydroxydopamine.
    Willis GL; Smith GC
    Brain Res; 1982 Aug; 245(2):345-52. PubMed ID: 6812852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function of lateral hypothalamic catecholamine and endorphin systems in the control of motor performance.
    Willis GL
    Pharmacol Biochem Behav; 1987 Oct; 28(2):197-202. PubMed ID: 2960985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal brain sites for apomorphine-induced circling and other stereotyped motor behaviour in the 6-hydroxydopamine-lesioned rat.
    Starr MS; Summerhayes M
    Neurosci Lett; 1982 Dec; 34(3):277-82. PubMed ID: 6819492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine-induced rotational behavior in rats: relationship to hypothalamic and striatal degeneration.
    Willis GL; Sandyk R
    Int J Neurosci; 1993; 71(1-4):135-46. PubMed ID: 8407140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.
    Duncan GE; Criswell HE; McCown TJ; Paul IA; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1027-34. PubMed ID: 3121842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivational versus motor impairment after haloperidol injection or 6-OHDA lesions in the ventral tegmental area or substantia nigra in rats.
    Papp M; Bal A
    Physiol Behav; 1986; 38(6):773-9. PubMed ID: 3103150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.
    Andringa G; van Oosten RV; Unger W; Hafmans TG; Veening J; Stoof JC; Cools AR
    Eur J Neurosci; 2000 Aug; 12(8):3033-43. PubMed ID: 10971644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal dopamine-rich grafts and 6-OHDA lesions independently provide partial protection from the adult nigrostriatal lesion syndrome.
    Rogers DC; Dunnett SB
    Behav Brain Res; 1989 Aug; 34(1-2):131-46. PubMed ID: 2504223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensification of cataleptic response in 6-hydroxydopamine-induced neurodegeneration of substantia nigra is not dependent on the degree of dopamine depletion.
    Srinivasan J; Schmidt WJ
    Synapse; 2004 Mar; 51(3):213-8. PubMed ID: 14666519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.